<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33">
 <label>33.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Penninger</surname>
    <given-names>JM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhong</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Slutsky</surname>
    <given-names>AS</given-names>
   </name>
  </person-group>
  <article-title>Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</article-title>. 
  <source>Intensive Care Med</source>
  <volume>46</volume>: 
  <fpage>586</fpage>â€“
  <lpage>590</lpage>, 
  <year>2020</year>. doi:
  <pub-id pub-id-type="doi">10.1007/s00134-020-05985-9</pub-id>. 
  <?supplied-pmid 32125455?>
  <pub-id pub-id-type="pmid">32125455</pub-id>
 </mixed-citation>
</ref>
